Fever alters proteins on lymphocytes making them better able to travel via blood vessels to reach the site of infection, stated new study published in Immunity.
"One good thing about fever is that it can promote lymphocyte trafficking to the site of infection, so you will have more immune cells in the infected region that will get rid of the pathogen," says Shanghai Institute of Biochemistry and Cell Biology (SIBCB) Professor and senior author JianFeng Chen.
To get to an infection, white blood cells need to adhere to the blood vessel and then transmigrate into the infected tissue or lymph node. During this step, molecules known as integrins are expressed on the surface of lymphocytes. Integrins are cell adhesion molecules that control lymphocyte trafficking during inflammation.
The researchers learned that fever-induced Hsp90 binds to the integrin tail and induces integrin activation. Moreover, one Hsp90 can bind to two integrins leading to a clustering of integrins on the lymphocyte surface. As a result, the clustered integrins activate a signaling pathway that promotes lymphocyte transmigration.
"Our findings show that this mechanism not only applies to lymphocytes but also to innate immune cells like monocytes," says Chen. "It is a general mechanism that can apply to lots of different immune cells expressing α4 integrins."
The team also used animal studies of bacterial infection and other fever models to confirm their findings. When the pathway between the Hsp90 and integrin was blocked, study mice died quickly. They also learned that this mechanism is very temperature-specific. "In this paper, we found the Hsp90 can only be induced at a temperature above 38.5°C," says Chen, explaining how the mechanism is targeted and effective, yet reversible.
The researchers also believe other stresses, not just fever, can induce Hsp90 expression. "That's why we think that in different situations, such as autoimmune disease and cancer, this Hsp90-α4 integrin pathway may be involved," says Chen. In autoimmune disease, aberrant trafficking of immune cells to different organs or tissues may lead to disease. "But if you block this pathway, you can maybe inhibit the trafficking of the immune cells during chronic inflammation or in autoimmune diseases," he says.